ProShare Advisors’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,266
| Closed | -$91.7K | – | 2180 |
|
|
2025
Q1 | $91.7K | Sell |
10,266
-2,406
| -19% | -$21.5K | ﹤0.01% | 1851 |
|
|
2024
Q4 | $119K | Buy |
+12,672
| New | +$119K | ﹤0.01% | 2036 |
|
|
2024
Q2 | – | Sell |
-12,219
| Closed | -$110K | – | 1999 |
|
|
2024
Q1 | $110K | Buy |
12,219
+508
| +4% | +$4.56K | ﹤0.01% | 1807 |
|
|
2023
Q4 | $132K | Buy |
11,711
+933
| +9% | +$10.5K | ﹤0.01% | 1741 |
|
|
2023
Q3 | $93K | Sell |
10,778
-984
| -8% | -$8.49K | ﹤0.01% | 1646 |
|
|
2023
Q2 | $122K | Sell |
11,762
-595
| -5% | -$6.16K | ﹤0.01% | 1664 |
|
|
2023
Q1 | $134K | Sell |
12,357
-1,617
| -12% | -$17.5K | ﹤0.01% | 1532 |
|
|
2022
Q4 | $157K | Buy |
13,974
+446
| +3% | +$5K | ﹤0.01% | 1552 |
|
|
2022
Q3 | $137K | Buy |
13,528
+366
| +3% | +$3.71K | ﹤0.01% | 1487 |
|
|
2022
Q2 | $119K | Sell |
13,162
-5,819
| -31% | -$52.6K | ﹤0.01% | 1585 |
|
|
2022
Q1 | $181K | Sell |
18,981
-4,508
| -19% | -$43K | ﹤0.01% | 1907 |
|
|
2021
Q4 | $260K | Buy |
23,489
+106
| +0.5% | +$1.17K | ﹤0.01% | 1872 |
|
|
2021
Q3 | $173K | Sell |
23,383
-2,177
| -9% | -$16.1K | ﹤0.01% | 1820 |
|
|
2021
Q2 | $371K | Buy |
25,560
+4,193
| +20% | +$60.9K | ﹤0.01% | 1744 |
|
|
2021
Q1 | $436K | Buy |
21,367
+1,161
| +6% | +$23.7K | ﹤0.01% | 1532 |
|
|
2020
Q4 | $359K | Buy |
20,206
+4,334
| +27% | +$77K | ﹤0.01% | 1488 |
|
|
2020
Q3 | $235K | Sell |
15,872
-460
| -3% | -$6.81K | ﹤0.01% | 1328 |
|
|
2020
Q2 | $343K | Buy |
16,332
+5,649
| +53% | +$119K | ﹤0.01% | 1151 |
|
|
2020
Q1 | $247K | Sell |
10,683
-7,652
| -42% | -$177K | ﹤0.01% | 934 |
|
|
2019
Q4 | $475K | Sell |
18,335
-2,030
| -10% | -$52.6K | ﹤0.01% | 1087 |
|
|
2019
Q3 | $397K | Sell |
20,365
-612
| -3% | -$11.9K | ﹤0.01% | 1077 |
|
|
2019
Q2 | $343K | Sell |
20,977
-2,611
| -11% | -$42.7K | ﹤0.01% | 1173 |
|
|
2019
Q1 | $535K | Buy |
23,588
+244
| +1% | +$5.53K | ﹤0.01% | 994 |
|
|
2018
Q4 | $597K | Sell |
23,344
-4,369
| -16% | -$112K | ﹤0.01% | 886 |
|
|
2018
Q3 | $905K | Sell |
27,713
-983
| -3% | -$32.1K | 0.01% | 865 |
|
|
2018
Q2 | $651K | Sell |
28,696
-1,860
| -6% | -$42.2K | ﹤0.01% | 1002 |
|
|
2018
Q1 | $741K | Sell |
30,556
-4,791
| -14% | -$116K | ﹤0.01% | 944 |
|
|
2017
Q4 | $986K | Buy |
35,347
+2,157
| +6% | +$60.2K | 0.01% | 846 |
|
|
2017
Q3 | $1.14M | Buy |
33,190
+2,110
| +7% | +$72.2K | 0.01% | 700 |
|
|
2017
Q2 | $1.24M | Sell |
31,080
-1,262
| -4% | -$50.3K | 0.01% | 667 |
|
|
2017
Q1 | $1.19M | Sell |
32,342
-8,418
| -21% | -$310K | 0.01% | 692 |
|
|
2016
Q4 | $1.3M | Buy |
40,760
+6,366
| +19% | +$203K | 0.01% | 670 |
|
|
2016
Q3 | $1.25M | Sell |
34,394
-5,388
| -14% | -$195K | 0.02% | 626 |
|
|
2016
Q2 | $903K | Buy |
39,782
+8,280
| +26% | +$188K | 0.01% | 755 |
|
|
2016
Q1 | $592K | Sell |
31,502
-3,085
| -9% | -$58K | 0.01% | 920 |
|
|
2015
Q4 | $567K | Buy |
34,587
+6,266
| +22% | +$103K | 0.01% | 988 |
|
|
2015
Q3 | $311K | Sell |
28,321
-1,905
| -6% | -$20.9K | ﹤0.01% | 1131 |
|
|
2015
Q2 | $394K | Sell |
30,226
-286
| -0.9% | -$3.73K | 0.01% | 1197 |
|
|
2015
Q1 | $529K | Buy |
30,512
+4,117
| +16% | +$71.4K | 0.01% | 1143 |
|
|
2014
Q4 | $394K | Buy |
26,395
+17,049
| +182% | +$254K | ﹤0.01% | 1338 |
|
|
2014
Q3 | $215K | Sell |
9,346
-2,974
| -24% | -$68.4K | ﹤0.01% | 1937 |
|
|
2014
Q2 | $393K | Buy |
+12,320
| New | +$393K | 0.01% | 1745 |
|